COMPLEX ADULT HEALTH FINAL IV ACTUAL
TEST SCRIPT 2026 COMPLETE QUESTIONS
AND ANSWERS GRADED A+
◉ Albuterol Indiciations. Answer: adrenergic used as a
bronchodilator to control & prevent reversible airway obstruction
caused by asthma or COPD
◉ Albuterol Side Effects. Answer: nervousness, restlessness, tremor,
HA, insomnia (occurs more in children), hyperactivity in children,
paradoxical bronchospasm (due to excessive use of inhales), chest
pain, palpitations, angina, arrhythmias, HPT, N/V, hyperglycemia,
hypokalemia, tremor
◉ Albuterol Interactions. Answer: MAOI's lead to hypertensive
crisis; beta blockers negate therapeutic effect; decrease digoxin
levels; risk of hypokalemia increases w/use of K+ losing diuretics
(hypokalemia increases the risk of digoxin toxicity); use w/caffeine-
containing herbs (cola nut, guarana, tea, coffee) increases stimulant
effect
◉ Albuterol Nursing Implications. Answer: monitor/report
tachycardia, heart palpitations, & chest pain; monitor/report
tremors
,◉ Albuterol Patient Teaching. Answer: report chest pain & heart
palpitations; report increase in pulse rate; avoid caffeine; notify PCP
if tremors interfere with ADLs
◉ T-PA Indications. Answer: tissue plasminogen activator &
recombinant approved by the U.S FDA for IV thrombolysis in acute
ischemic stroke w/in 3 hours of onset of stroke symptoms; only
approved for PT's 18yo & older
◉ t-PA. Answer: Alteplase
◉ Albuterol. Answer: Ventolin
◉ T-PA Precautions/Contraindications. Answer: unclear
time/unwitnessed symptom onset/last known baseline state greater
than 3-4.5 hrs; current or HX of IC hemorrhage; CT showing
hypoattenuation or hypoperfusion representing irreversible injury;
recent (w/in 3 months) ischemic stroke, severe head trauma, or
intracranial/intraspinal surgery; Subarachnoid hemorrhage; GI
malignancy or GI bleed within 21 days of stroke event; IC conditions
that may increase risk of bleeding (such as intracranial neoplasm,
arteriovenous malformation, or aneurysm); Coagulopathy; Low
molecular weight heparin (LMWH) treatment doses within the
previous 24 hrs; Current use of anticoagulant with INR > 1.7 or PT >
15 seconds; Current use of direct thrombin inhibitors or direct
factor Xa inhibitors w/elevated laboratory tests; Concurrent use of
glycoprotein IIb/IIIa receptor inhibitors; Infective endocarditis;
,Aortic arch dissection; Intra-axial intracranial neoplasm - lesions
located within the brain tissue
◉ T-PA Adverse Effects. Answer: Bleeding (most common);
Orolingual angioedema; Arrhythmias; Hypotension; Edema;
Cholesterol embolization; Venous thrombosis; Re-embolization of
deep venous thrombi (DVT) in patients with pulmonary embolims;
Nausea; Vomiting; Hypersensitivity reactions
◉ T-PA Interactions. Answer: Warfarin; aspirin (ASA); NSAID's
(Ibuprofen, Naproxen, Nabumetone, and platelet inhibitors such as-
Plavix, Effeint, Kengreal, and Brilinta); BC Alteplase breaks down
clots & interferes w/the body's ability to stop bleeding, any drugs
that also interfere w/the body's ability to form blood clots can
increase the risk of bleeding in patients
◉ T-PA Patient Teaching. Answer: must be used w/in 8 hrs of being
opened; can alter the test results of coagulation & fibrinolytic
activity tests; have patient immediately report to the PCP any signs
of bleeding (vomiting blood or vomit that looks like coffee grounds;
coughing up blood; hematuria; black, red, or tarry stools; bleeding
from the gums; abnormal vaginal bleedings; bruises without a
reason or that get better); immediately report to the PCP any signs
of DVT (edema, warmth, numbness, change in color, or pain in the
extremities); report to PCP any severe cerebrovascular disease
(change in strength on 1 side is greater than the other, difficulty
speaking or thinking, change in balance, or visual changes)
, ◉ Amiodarone. Answer: Cordarone
◉ Amiodarone Indications. Answer: class III potassium channel
blocker that manages life-threatening ventricular-tachycardia or
fibrillation that's resistant to other drugs; may treat some atrial
dysrhythmias, such as atrial fibrillation
◉ Amiodarone Contraindications/Precautions. Answer: cardiogenic
shock; sick sinus syndrome, 2nd- or 3rd-degree AV block,
bradycardia leading to syncope without a functioning pacemaker;
any known hypersensitivity to the drug or to any of its components,
including iodine; pulmonary toxicity; hepatic injury; worsened
arrhythmia; visual impairment or loss of vision; thyroid
abnormalities; bradycardia; implantable cardiac devices; fetal
toxicity; peripheral neuropathy; photosensitivity & skin
discoloration; surgery
◉ Amiodarone Adverse Effects. Answer: N/V; constipation;
pulmonary toxicity w/ pneumonitis (causing fever, cough, SOB),
occurs most frequently w/ long-term and/or high-dose use and may
lead to pulmonary fibrosis); visual effects-optic neuropathy
w/possible blindness & corneal microdeposits, which may cause
severe sensitivity to light, blurred vision; cardia effects-bradycardia
& hypotension (common w/ IV dose); heart failure may be worsened
by amiodarone therapy; blue-grey discoloration of the skin; CNS
effects-dizziness, tremor, hallucinations
TEST SCRIPT 2026 COMPLETE QUESTIONS
AND ANSWERS GRADED A+
◉ Albuterol Indiciations. Answer: adrenergic used as a
bronchodilator to control & prevent reversible airway obstruction
caused by asthma or COPD
◉ Albuterol Side Effects. Answer: nervousness, restlessness, tremor,
HA, insomnia (occurs more in children), hyperactivity in children,
paradoxical bronchospasm (due to excessive use of inhales), chest
pain, palpitations, angina, arrhythmias, HPT, N/V, hyperglycemia,
hypokalemia, tremor
◉ Albuterol Interactions. Answer: MAOI's lead to hypertensive
crisis; beta blockers negate therapeutic effect; decrease digoxin
levels; risk of hypokalemia increases w/use of K+ losing diuretics
(hypokalemia increases the risk of digoxin toxicity); use w/caffeine-
containing herbs (cola nut, guarana, tea, coffee) increases stimulant
effect
◉ Albuterol Nursing Implications. Answer: monitor/report
tachycardia, heart palpitations, & chest pain; monitor/report
tremors
,◉ Albuterol Patient Teaching. Answer: report chest pain & heart
palpitations; report increase in pulse rate; avoid caffeine; notify PCP
if tremors interfere with ADLs
◉ T-PA Indications. Answer: tissue plasminogen activator &
recombinant approved by the U.S FDA for IV thrombolysis in acute
ischemic stroke w/in 3 hours of onset of stroke symptoms; only
approved for PT's 18yo & older
◉ t-PA. Answer: Alteplase
◉ Albuterol. Answer: Ventolin
◉ T-PA Precautions/Contraindications. Answer: unclear
time/unwitnessed symptom onset/last known baseline state greater
than 3-4.5 hrs; current or HX of IC hemorrhage; CT showing
hypoattenuation or hypoperfusion representing irreversible injury;
recent (w/in 3 months) ischemic stroke, severe head trauma, or
intracranial/intraspinal surgery; Subarachnoid hemorrhage; GI
malignancy or GI bleed within 21 days of stroke event; IC conditions
that may increase risk of bleeding (such as intracranial neoplasm,
arteriovenous malformation, or aneurysm); Coagulopathy; Low
molecular weight heparin (LMWH) treatment doses within the
previous 24 hrs; Current use of anticoagulant with INR > 1.7 or PT >
15 seconds; Current use of direct thrombin inhibitors or direct
factor Xa inhibitors w/elevated laboratory tests; Concurrent use of
glycoprotein IIb/IIIa receptor inhibitors; Infective endocarditis;
,Aortic arch dissection; Intra-axial intracranial neoplasm - lesions
located within the brain tissue
◉ T-PA Adverse Effects. Answer: Bleeding (most common);
Orolingual angioedema; Arrhythmias; Hypotension; Edema;
Cholesterol embolization; Venous thrombosis; Re-embolization of
deep venous thrombi (DVT) in patients with pulmonary embolims;
Nausea; Vomiting; Hypersensitivity reactions
◉ T-PA Interactions. Answer: Warfarin; aspirin (ASA); NSAID's
(Ibuprofen, Naproxen, Nabumetone, and platelet inhibitors such as-
Plavix, Effeint, Kengreal, and Brilinta); BC Alteplase breaks down
clots & interferes w/the body's ability to stop bleeding, any drugs
that also interfere w/the body's ability to form blood clots can
increase the risk of bleeding in patients
◉ T-PA Patient Teaching. Answer: must be used w/in 8 hrs of being
opened; can alter the test results of coagulation & fibrinolytic
activity tests; have patient immediately report to the PCP any signs
of bleeding (vomiting blood or vomit that looks like coffee grounds;
coughing up blood; hematuria; black, red, or tarry stools; bleeding
from the gums; abnormal vaginal bleedings; bruises without a
reason or that get better); immediately report to the PCP any signs
of DVT (edema, warmth, numbness, change in color, or pain in the
extremities); report to PCP any severe cerebrovascular disease
(change in strength on 1 side is greater than the other, difficulty
speaking or thinking, change in balance, or visual changes)
, ◉ Amiodarone. Answer: Cordarone
◉ Amiodarone Indications. Answer: class III potassium channel
blocker that manages life-threatening ventricular-tachycardia or
fibrillation that's resistant to other drugs; may treat some atrial
dysrhythmias, such as atrial fibrillation
◉ Amiodarone Contraindications/Precautions. Answer: cardiogenic
shock; sick sinus syndrome, 2nd- or 3rd-degree AV block,
bradycardia leading to syncope without a functioning pacemaker;
any known hypersensitivity to the drug or to any of its components,
including iodine; pulmonary toxicity; hepatic injury; worsened
arrhythmia; visual impairment or loss of vision; thyroid
abnormalities; bradycardia; implantable cardiac devices; fetal
toxicity; peripheral neuropathy; photosensitivity & skin
discoloration; surgery
◉ Amiodarone Adverse Effects. Answer: N/V; constipation;
pulmonary toxicity w/ pneumonitis (causing fever, cough, SOB),
occurs most frequently w/ long-term and/or high-dose use and may
lead to pulmonary fibrosis); visual effects-optic neuropathy
w/possible blindness & corneal microdeposits, which may cause
severe sensitivity to light, blurred vision; cardia effects-bradycardia
& hypotension (common w/ IV dose); heart failure may be worsened
by amiodarone therapy; blue-grey discoloration of the skin; CNS
effects-dizziness, tremor, hallucinations
